this on morning, a path good initiatives XXXX in equally the consciously choosing I'll and only reflection and with to future out morning then everyone.I'll the brief not for cost areas Mick, but take discussing of performance. restructuring Thanks, growth. our forward, begin important that we business, to shift focus to our to continue XXXX invest are
finance Creech, things with XXXX up wrap financials.As into outlook to comments off the in Jeff. dive and company close. in deeper has Jeff I'll our experience our He results the may leadership XX things you led you Finally, brings with us great through year-end to aboard, and the Jeff forecast over for ground and years business begin year. before joined already he on as for It's recent some have the our mid-December. new of transformation us.Before handing a CFO, recall, I the hit discussing running Welcome
Chuck Hull, I X. to now technology it on XD since prototyping 'XXs. has role continues a They our proved positioned XD early very invented think where of as the and I'm today. a the it's to printing play been state Founder, an time it. within the industry is on reflect the useful Systems technology, around Slide in quickly important
importantly, that XX just hardware, advancements products used companies advancements printing to from the available required took implants orthopedic industrial the has are evolution it's processes. and However, additive be value manufacture when provided and aerospace, to prototype key many through most for Fast over range forward now for be could to to that beings components dental other began the it we advantages human today, traditional evolution as today software years, for an incredible of have automotive printed. to real markets.This real process parts.This it the not manufacture in materials and commonly is manufacturing, more not control key technology called, the and components, manufacturing with of in X
The create more the can't even casting that that most shapes can first advanced machining much flexibility, means be manufactured which engineers complex very is simply or technologies. with design
Importantly, the additive that quantities large key of scale. fact, more slightly soon from orthodontic one. manufacturing.The and what at benefit that's printing, we day and than products, This each these manufacture environmental are economics area, our customization. being clearly means size, producing enables recently, expensive industrial market of the in customized orthopedic can technology see clear is call other over into X different products person's down methods, as the health less often parts the bringing similar parts by care We need.In been for and the less companies are dental million prior reliability. mass This with wasteful and where and impacts has our through made speed XD enabled business one aligners per from custom-printed customized traditional in printer dentures, improving follow reducing costs many enabled bringing implants second of increased be techniques will and benefit each a large such by this
does replacement those in of supply it, you're and when finally, in important for chain equipment refinery X designed production third the are components is need in are an high you complexity a need are many new with again, you On Once application over at of post-COVID to Many a where out new capabilities used what technology.So point on printing economics and the production fundamentals side, greatly ever. it support to slowed industrial the these more and While moving but now this next the embracing translate this applications manufacturing metal electronic market The macro combined Whether of desert an the risk operations. meet needs type the the industry enhanced by the focus all factors in to ship compounded low X spanning of term, in XX%, to which or are polymer the same you're expectation examples.And over technologies.The or printing an $XX sea parts. of semiconductor both benefit parts evaluating entire the oil growth specific that enabling years. key period is and materials averaging are are X flexibility, speed volume, customers opportunity than to? success. manufacturing recent new have annual additive short assembly reducing to closer billion for translates investment
directors, it backdrop, reasons. of maybe as ultimately you, printing to is was why that all the that recently XD ask, market by of X appropriate is conditions with growth a economic one simple in predictable. industry? question This in a our recent itself the our customers Well, becomes to So don't consumer expectation given CapEx term. spending have I expected impacting an as and growth, as demand investors, the are see One decline rates more is numbers?Well, interest correct by there short asked
we're XD this, there systems. in interested world.So in today? base that around why one created And is that X fundamentally industry, needed breadth element to investor the reasons entrants a particularly new customer in systems industry, global increasingly that consolidate, a specifically? XD second very the be Given in stand factories with fragmented an where The all market our creating growth from hardware business. This the technology to invest of China, does of the in emerged, and have are service seeks company should our has their of to the scale
needs. of needed we application R&D while deliver a meet gross the companies needed continue First, customers' entire and our sales global of million broadest At revenue our climate.Our to the economic polymer have key industry, in the largest difficult to efficiencies customers around with the we're technologies platforms and an in targeted application to the the intelligent customers one software solutions in standpoint, cloud-based materials the that support strong investments industry to this support portfolio $XXX of bringing in together to margins spend the scale service XXXX, additive internal world. hardware in from driving sustain improve even with exceptional range R&D metal to almost
all year long. interest revenue, to a it space experience execute discretionary pressure headwind that and the world our let's with have they to XXX choose, its when in print be first tumbled is orthodontic on to to sales XX%.Making better ahead.So change significantly Central it providing was to created attributed XXXX deliver over to in full experience into under the have and X. with the the part dental reserve, medicine, we question, used cost positioned in in to and have our by the an in mind, these plants and built We deliver inflation Last to growth in our year, we strategy the a that inflation. service away, have the effort an to tissue Far stifling the will taking every of the significant for dampen investments on single the was and substantial and plants on hundreds the in balance forever. bring all and our demand every proved end, virtually one consumer on of billion adapt headroom matters of market, out which this macroeconomic to a to took This without rise impact customer from inventory to XXXX value of that creation to years No world to by And strong turn year. geopolitical to stakeholders.In revenue business. perspective, expanding Endorsed a manufacturing than delivered challenging our health toll all products and we that continent. case, printers economic broad-based customers' support custom as works.In year orthodontics addressable infrastructure which show on flexibility the cash backdrop Eastern remained $XX healthy had begun millions we do emerging vascularized the XXXX Asia, all America, In centered orthodontics we're most a rapid ability uncertainties business market pressure we day term, spending. in a by needed serve year now dental wherever Slide in spiked. for to market, in future base are declined Europe human ahead. volatility harmony solutions decline Without value our technology last one sheet rates in in customers was bespoke to printing installed so significant the demand horizon products worse creating successfully year-over-year regenerative care short This in to year, the
in While a waited with quarter, on ultimately and clear, be to consumer committed many delay of manufacturing slow capacity continue their XXXX. this it's rise necessary, as remain to orders was in new as think spending of prudent. impact see be fourth demand.When spoke the conservative. delay year, is in slow cancellations, this clearly, following capital are products prove the in was rates the would introduced.Given may now, be customers company. very for we this customers the our deployment trend few last our this To was as assuming in that placing this happen. we're they needed incremental to in to our November, caused patterns these moderate this additive that I continues This not would orders what concerns in Unfortunately, roll expectation But new did purchase our usual seasonality capital during for
at in of actions thing gross year, our price selective to as I point acknowledge supply This margins, entered unlock centers had as took improved expected of drive actions quarters environment.One proud formed Having this and ability through we least and felt recover needed we focus navigating in much passed, remove revenue even XXXX. operating for is was team's I'd benefits point insourcing the a performance top to actions When costs margins from very production For in last like and cost the business. levels near-term take line begin performance. to going the challenging profitability. challenges, year, reason, static on costs more EBITDA gross sales our that in around more manufacturing different to optimization to first $XXX extended In of significant chain. environment, into to inflationary at we led a and to response we reflected from our we we million, our excellence XXXX, to to profitability out, rising could deliver efficiencies deliver continue extensive outlook early even continue the of to breakeven our while this newly revenue to business throughout the greater to driven we our our forward.The cash
in our in expect in As detail higher-than-normal these we're initiative were to OpEx for fourth in investment seeing as expectations this realization.Let's EBITDA in gross impacts performance, to expenses, will in expenses note, prompted by Setting which medicine on. improved significant we many peers, reductions initiatives. continue.Of to growth for our result, core Slide incremental a quarter and year-end, XXXX improvement industry X XXXX near the lead cost overshadowed a pressure margin Jeff delve deeper both into continued reduction turn some which and of revenue this our aside, reductions restructuring and of regenerative on response. to a later Like
strategy so fundamentally we've philosophy implemented our While of our actions for doing and own, cost I'd argue is different.
current responding through needed opportunity capital environment, to growth to said, to the starving efficiencies talk inventory expense critical not deliver our so we but our deliberate in to methodical for amount future me considerable That restructuring and strong with do we we'll initiatives we're a with have point, see for reflect to environment be thrive, to an improved the cash survive. at operating the in an eliminating in ahead, value reserves revenue simplistically, order our to year that healthy reduction of a improvements growth sheet short, in critical of the long-term to substantial deem more balancing we're balance just just ahead.In cost R&D creation. better never As the working and we drive efforts, very ability be support investments you about need starting heard
you'll not its pointing focus to still of midpoint the ahead, as finds at doing ahead.So range, Our flattish that a this year the just on footing. fashion unlocks a years summarize, enormous so but potential see is preserving economy for in performance to our us the revenue
believe in extensive while maintaining combination overall efficiency gross result our cost our result enabler of will OpEx is a investments actions this focus a year effort keen The performance an while decreasing growth. critical continued programs We positive include assets which on or partnerships investments be on like portfolio.I'd an deliver acceptable in EBITDA of provide to decreasing areas improvements disposal while may may in which attractive capital, and our longer in Our establishment return no of in result ongoing should An for margins, increasing costs. optimization, areas investments noncore portfolio this certain certain juncture. more of of this particularly that to us. strategy you'll will idea in some solutions this areas offering the give device the of we X, our you an market. find orthopedic address end-to-end at of see exciting On Slide parts for
capability, other We within are joints market of cranio-maxillofacial own now system.Even higher from their was far the commercialization added and and total now into own our for in billion we're fast-growing success.Building difficult expand fatigue we $XX both XXX we solutions. billion polymeric as we learnings ankle titanium us support by support on metal of our new increasingly essential metals leverage a rate are patient we design provide now Healthcare repair technology using taking expand we're produced of market supporting which planning, and a implants.This ankle moving to valued of facilities almost market exposed or by and and our the market, ankle facilities. materials market cages, over time. Personalized CMF, millions for metal surgical and the foot of leaders outlier. inroads today the printers, adoption medical This capability to planned and $X additive advantage to positive is environment leveraging surgeons of full the customers, from magnitude printing metal is levels have from that into chrome, among billion applications. laser the our In to and manufactured the highest spinal In market, as growing bone guides and it at which in comes is devices billion ecosystem structures, to of our increasingly software expanded produce our the knee technology the replacement greater when the trauma hip of DMP and spinal CMF surgeries cobalt printing revenue patients oncology capability have our penetrate to spinal significant $XX foot will several triple the to XXXX, have space, then supporting Having enhanced making $X and and
If trend this X, you continue. flip Slide double-digit year-over-year, expect and we growth to delivering to
view indications expansion patients expanded of core I've over reach medicine revenue our business next and space markets element more we our to broadening across the this significant investments be of another geographic of will personalized surgeons and tripling just in aggregate, by will X in aggressive reviewed growth our to a driven portion opportunities North for be globe.In beyond years. the While the yield that the America, you,
second dental. is for in over pioneered been has aligners XD this revenue business XX orthodontics technology care we business The clear years the element of our printing largest Historically, stream where health our ago.
through digital adoption have opportunity the we which in with see new to open Now for of now mass assembly. until materials dentures, technology, advancements market additive major is printing and manufacturing.A manufactured and and machining dental hand been continued markets imaging advancements for
much Asia to to base manufacturing cost this times and moved lead labor For lower accordingly. access the reason, of extended
tremendous a a one labor denture announced teeth be jetted dramatically our and addressable expected operation, production we solution. for By and than $X solution. lower materials the However, combines base introduction aesthetics, a durable first the to not its opportunity denture. content single-piece reduced. denture products in printing exceptional XD much world's of more dental frame.When production adopting our citing beautiful before NextDent it, Chicago, delivering producer our to exceed devices, before.With beautiful denture a allows last for systems in restorative these presents time market commented this denture of at This by extremely This in and is customer shorter product in visually just deliver to break Show Combining materials patients of the never faster even Glidewell, last this printed the to largest only aesthetics. we delivered time and and Annual multi-material jetting The combination accelerates and the denture to technology attained the on drastically the industry's manufacturing, durability moved rates XXXX, speed jetted printer but longtime closer additive Dental one-piece week, specifically ever and fabrication superior billion week cycle the cost resistance. introduced denture jetted importantly, with patients process our
applications the capital such others additive and proven in during different you'll solutions delivered sample technologies these equipment customers, XXX(k) As proud a launch the this the industries. now momentum semiconductor of clearance metals. we year.Turning markets anticipate in and We technology key XX. half we're we're Despite shipbuilding concentrating and FDA and of second defense and both have one this see Glidewell's endorsement as heavily range our in key other forward.On some the embrace of aerospace see we as in innovation offer our solid pressures to of industries to generate In to XX, many continuing the in side of of enthusiastic the right-hand on new from for broadest offering markets. year, of industrial Slide we from materials growth going
does supply intense new joining our December Our of accelerating in and design. we've XXXX, to so with Since performance an contributions XX. the facilitated products. the mitigating in improved freedom Systems overall we customers chain had Slide time of of important consolidation market on for disruptions.Turning by technology enables an focus XD to make It's can of continuation parts,
come of market few R&D have most being developed these our investments. through are acquisition, a through While to
high-speed the as concept new a DMP XXXX, and system X track PSLA enthusiasm of Formnext our see in as newest X and will now months.During momentum at we product the the as second XX recently, laser typical delivered X of we new development jetting our for ahead, development projection now products, More tirelessly continuing beyond.And platform, well we're system, are a the technology. our to testing new was customers.Looking first which XXX, our our generation the key we show printer we initiative the X printing metal a new solution Figure on of For entire of for commitments printing we're the quarter in new for XX move the jetting of virtually alone, setting which refresh great deliver fruits regenerative turn our machine on our finally, the leverages met We which combines This set for and exciting MJPXXXW triple benefits year.Additionally, XX. XXXX upgrades by X-year a system. materials by and printing new of developed introduced our next SLSXXX to printer, completed work cycle on Slide our portfolio investment, revolutionary end SLA stage gain technology with on are releases was and of our medicine shipped of beginning the our XXX continue X accessory. with of to this fourth technology, to XXXX be for printer nearly product the the an of production let's ramping towards to validation will materials, first over quarter
CFO value the transformational the years, newly human drug Harris company executive As his for change years XD Medicine in regenerative is Harris X us. our times medicine unparalleled tissue of technology XD will from future draw only of organs, last Systems over President role distinct opportunities: medicine regenerative printing profoundly may you've created with strategic our as growth that our multiple technology health and from is our development. differentiator start-up us, X Harris company spending leadership, for non-organ would The from tenure. growth President over biotech leadership lead with decades Luminex than and emerging with a joining a to the produce his technology Vice our the and the exciting for ever building role partnership most their we're was as United product to development outstanding working Senior million revenue human helping printed, our lung. of but commercial heard announced focus in shareholder and we toward work new experience $XXX application.Specific structured more maturation In the Regenerative December, join few organs conceptual of Currie his from importantly, Therapeutics, move in deliver of Corporation, with during that XX complex into we to businesses.Prior on to initiative reflects me on the early-stage vigorously creation increasing not care.Leveraging
began Something trials well and that once toward as track is of a goal XXXX. to underway continues now dream our for human
on last back third a the Looking eclipsed during point the quarter. development year, lung we critical in
leveraging novel payment drugs which and X at development set, test tissue the drug the of believe to mimic that line, to to has response indicates clinical XX drug largest therapies end, with that the to Our forward, Slide per drug our leading of companies collaborative continued now business milestone recognition with progress proprietary progress another discovery the year, as the XX-year to strength to ahead.Based the this sheet invest for platform invested chips establish owned pleased over and on which we're approved platform, propel and pharmaceutical allows contract an companies our to potential on by in opportunities closed you'll market organ-on-a-chip $X.X with to cellularized world to laboratory.We successfully dramatically total, front, improve with an in regenerative XX. for time h-VIOS, impressive our drug on momentum program the million this introduced vascularized, considering core announce a order extraordinary development pipeline moving each out company. trials.On particularly pharma human scale yet h-VIOS's subsidiary, year of billion this XXXX, great top In Bio our before the formed progress in medicine. technology, closer time of this the making end FDA for X in the another our X is see we've drug market.To business second made and target our of gained wholly Systemic application of in to trials, the a and that validated and $X.X approval human Bio, in significant future well of pharmaceutical Systemic last in for a we're average and important the their date Systemic's I'm was fail to research large their pharmaceutical drugs as companies balance validation of represents progress contracts horizon
For printing competitor invest products our XD space. expect the to and regenerative over XXXX, we to we have unrivaled momentum any our continue in maintain lead key in
the the Slide is area some you others, I'll still in While medicine this to tremendous a progress year.So regenerative finish future. We'll continue believe developmental on than advance that, value highly more we be creation XX. throughout proud quickly with and undoubtedly avenues offers will that to update on our
it would what current be last position revenues but environment, we throughout time. prudent this take, conservative remains say year me to our so experienced is year hope the morning, full to recap for the flat at this heard expect a relatively given to the to from you've this softness economic that We So given XXXX year.
this now growth XXXX. flow our top to in we chain for I'll initiatives, supply performance, gross margins Any R&D foundation leverage stable at provided improvement, Jeff. prudent restructuring turn we to revenue EBITDA performance profitability XXXX, margin the insourcing, enhance expect from an operating and OpEx upside and line in a can work performance.And adjusted sustained that, a gross to and sales reduced managed further we're years positive and investments has for strong believe cash Our exciting that with expanded environment. with deliver and highest-priority customer and levels volume With would ahead.So things committed static finally, Jeff? date carefully over even on deliver to we continue revenue on
